Details of the Drug Reposition

General Information of This Drug (ID: DMNXT8C)

• Drug Name: Ultra-rapid insulin (DMNXT8C)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Type-1 diabetes	DIS7HLUB	5A10	Phase 2	[1]
Type-2 diabetes	DIS3X247	5A11	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)